T. Rowe Price Associates’s Aptevo Therapeutics APVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$16K Hold
2023
Q2
$68K Hold
2023
Q1
$95K Hold
2022
Q4
$107K Hold
2022
Q3
$141K Hold
2022
Q2
$165K Hold
2022
Q1
$271K Hold
2021
Q4
$364K Buy
2021
Q1
Hold
2020
Q4
Hold
2017
Q4
Hold
2017
Q3
Hold
2017
Q2
Hold
2017
Q1
Hold
2016
Q4
Hold
2016
Q3
Hold